Medulloblastoma Clinical Trials
Medulloblastoma is a complex diagnoses, and treatment options continue to evolve. Clinical trials may be one option to consider as you explore what comes next.
We've provided a pre-filtered search through www.clinicaltrials.gov to help you find trials that are currently recruiting or active for medulloblastoma.
If you have questions about finding clinical trials that are available, please reach out and we are more than happy to help.
Please Note: The most accurate and up-to-date trial information can be found by accessing ClinicalTrials.gov using the link above.
Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)
Last Updated: 2024-06-07
Originally Posted: 2024-01-05
Integrated PET/MRI and Germline Variants to Differentiate Brain Tumopr Recurrence From Iatrogenicchanges in Children
Last Updated: 2024-01-26
Originally Posted: 2024-01-26
Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour
Last Updated: 2023-11-28
Originally Posted: 2022-02-09
Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma
Last Updated: 2023-11-21
Originally Posted: 2016-03-31
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Last Updated: 2023-11-21
Originally Posted: 2022-05-19
Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer
Last Updated: 2023-11-21
Originally Posted: 2021-11-03
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
Last Updated: 2023-11-08
Originally Posted: 2022-09-10
Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial
Last Updated: 2023-10-30
Originally Posted: 2020-03-25
Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)
Last Updated: 2023-10-30
Originally Posted: 2017-07-11
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
Last Updated: 2023-10-30
Originally Posted: 2017-05-16
Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)
Last Updated: 2023-10-23
Originally Posted: 2017-07-11
Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial
Last Updated: 2023-10-23
Originally Posted: 2020-02-26
Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial)
Last Updated: 2023-10-23
Originally Posted: 2019-12-12
Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid Tumors
Last Updated: 2023-10-23
Originally Posted: 2022-06-23
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
Last Updated: 2023-09-28
Originally Posted: 2021-01-06
Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers
Last Updated: 2023-09-21
Originally Posted: 2017-06-02
Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System
Last Updated: 2023-08-31
Originally Posted: 2021-02-08
Quantitative Assessment of Radiation-induced Neuroinflammation - A Proof of Principle Study
Last Updated: 2023-08-21
Originally Posted: 2021-11-22
Personalized Risk-Adapted Therapy in Post-Pubertal Patients With Newly-Diagnosed Medulloblastoma
Last Updated: 2023-08-14
Originally Posted: 2020-05-26
Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors
Last Updated: 2023-08-14
Originally Posted: 2020-04-07
Study of Stored Tumor Samples in Young Patients With Brain Tumors
Last Updated: 2023-08-02
Originally Posted: 2009-05-12
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Last Updated: 2023-08-01
Originally Posted: 2019-04-11
Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer
Last Updated: 2023-07-27
Originally Posted: 2019-05-03
Rare Embryonal Tumors of the Central Nervous System: International Registry
Last Updated: 2023-07-21
Originally Posted: 2023-02-03
Feasibility and Acceptability of Horse Therapy for Children, Adolescents and Young Adults in Remission From Medulloblastoma
Last Updated: 2023-07-13
Originally Posted: 2023-03-06
Methionine PET/CT Studies In Patients With Cancer
Last Updated: 2023-07-06
Originally Posted: 2009-02-10
A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Last Updated: 2023-07-05
Originally Posted: 2022-01-20
Methotrexate and Etoposide Infusions Into the Fourth Ventricle in Children With Recurrent Posterior Fossa Brain Tumors
Last Updated: 2023-06-22
Originally Posted: 2016-09-19
Infusion of Panobinostat (MTX110) Into the Fourth Ventricle in Children and Adults With Recurrent Medulloblastoma
Last Updated: 2023-06-22
Originally Posted: 2020-03-19
HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors
Last Updated: 2023-06-06
Originally Posted: 2016-08-23
Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery
Last Updated: 2023-04-28
Originally Posted: 2019-04-05
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma and ATRT
Last Updated: 2023-04-21
Originally Posted: 2011-05-19
Apatinib Combined With Temozolomide and Etoposide Capsules in the Treatment of Recurrent Medulloblastoma in Children
Last Updated: 2023-04-19
Originally Posted: 2020-08-06
Auto Transplant for High Risk or Relapsed Solid or CNS Tumors
Last Updated: 2023-04-05
Originally Posted: 2012-01-06
Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma
Last Updated: 2023-03-13
Originally Posted: 2020-12-10
68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.
Last Updated: 2023-03-01
Originally Posted: 2019-09-09
DOTATOC PET/CT for Imaging NET Patients
Last Updated: 2023-02-21
Originally Posted: 2018-07-11
Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma
Last Updated: 2023-02-08
Originally Posted: 2021-09-27
Genetic and Molecular Risk Profiles of Pediatric Malignant Brain Tumors in China
Last Updated: 2023-01-05
Originally Posted: 2023-01-05
Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors
Last Updated: 2022-12-20
Originally Posted: 2015-10-14
HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors
Last Updated: 2022-12-19
Originally Posted: 2018-04-18
Focal Radiotherapy Plus Low Dose Craniospinal Irradiation Followed by Adjuvant Chemotherapy in WNT Medulloblastoma.
Last Updated: 2022-10-24
Originally Posted: 2020-07-17
NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors
Last Updated: 2021-11-23
Originally Posted: 2021-11-23
Efficacy of Dual Task Training on Children With Ataxia After Medulloblastoma Resection
Last Updated: 2021-11-18
Originally Posted: 2021-11-18
Memory Neuroimaging in Children, Adolescents and Young Adults Following Pediatric Cancer
Last Updated: 2021-05-03
Originally Posted: 2020-03-27